Cardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndrome
- PMID: 25115868
- PMCID: PMC4130542
- DOI: 10.1371/journal.pone.0104637
Cardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndrome
Abstract
SHROB rats have been suggested as a model for metabolic syndrome (MetS) as a situation prior to the onset of CVD or type-2 diabetes, but information on descriptive biochemical parameters for this model is limited. Here, we extensively evaluate parameters related to CVD and oxidative stress (OS) in SHROB rats. SHROB rats were monitored for 15 weeks and compared to a control group of Wistar rats. Body weight was recorded weekly. At the end of the study, parameters related to CVD and OS were evaluated in plasma, urine and different organs. SHROB rats presented statistically significant differences from Wistar rats in CVD risk factors: total cholesterol, LDL-cholesterol, triglycerides, apoA1, apoB100, abdominal fat, insulin, blood pressure, C-reactive protein, ICAM-1 and PAI-1. In adipose tissue, liver and brain, the endogenous antioxidant systems were activated, yet there was no significant oxidative damage to lipids (MDA) or proteins (carbonylation). We conclude that SHROB rats present significant alterations in parameters related to inflammation, endothelial dysfunction, thrombotic activity, insulin resistance and OS measured in plasma as well as enhanced redox defence systems in vital organs that will be useful as markers of MetS and CVD for nutrition interventions.
Conflict of interest statement
References
-
- Grundy SM (2008) Metabolic syndrome pandemic. Arteriosc Thormb Vasc Biol 28: 629–36. - PubMed
-
- Eckel RH, Alberti KGMM, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. The Lancet 375 : 2010, 181–83. - PubMed
-
- Festa A, D'Agostino R, Howard G, Mykkännen L, Tracy RP, et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS). Circulation 102: 42–47. - PubMed
-
- Armutcu F, Ataymen M, Atmaca H, Gurel A (2008) Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem Lab Med 46: 785–90. - PubMed
-
- Güclü F, Özmen B, Hekimsoy Z, Kirmaz C (2004) Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. Biomed Pharmacother 58: 614–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
